Skip to main content
. 2023 Nov 2;15(2):117–123. doi: 10.1136/flgastro-2023-102485

Table 4.

Follow-up outcomes

Variable Total (n=964) Grade C (n=595) Grade D (n=369) P value
Interval oesophagogastroduodenoscopy (OGD1) to OGD2 (weeks), median (IQR) 10.1 (7.8–20.4) 10.2 (7.6–21.3) 10.1 (7.4–19.9) 0.800
Biopsies taken at OGD2, % (N) 34.3 (132/385) 31.8 (75/236) 38.3 (57/149) 0.192
Macroscopic appearance OGD2, % (N) Completely healed 66.2 (255/385) 69.9 (165/236) 60.4 (90/149) 0.055
Grade A 6.2 (24/385) 7.2 (17/236) 4.7 (7/149) 0.322
Grade B 4.9 (19/385) 5.1 (12/236) 4.7 (7/149) 0.865
Grade C 9.4 (36/385) 7.6 (18/236) 12.1 (18/149) 0.144
Grade D 3.1 (12/385) 2.1 (5/236) 4.7 (7/149) 0.156
Grade not specified 10.1 (39/385) 8.1 (19/236) 13.4 (20/149) 0.089
New stricture OGD2, % (N) 2.3 (9/385) 1.7 (4/236) 3.4 (5/149) 0.294
New cancer OGD2, % (N) 0.3 (1/385) 0.4 (1/236) 0 (0/149) 0.426
New atypia OGD2, % (N) 1.8 (7/385) 2.1 (5/236) 1.3 (2/149) 0.579
New dysplasia OGD2, % (N) 0.5 (2/385) 0.4 (1//236) 0.7 (1/149) 0.742
New IM OGD2, % (N) 7.0 (27/385) 4.7 (11/236) 10.7 (16/149) 0.023*
New combined Barrett’s appearances and IM on OGD2, % (N) 10.1 (39/385) 6.8 (16/236) 15.4 (23/149) 0.006*
New Barrett’s appearances on OGD2, % (N) 3.1 (12/385) 2.1 (5/236) 4.7 (7/149) 0.156
Prague classification C OGD2 (cm), median (IQR) 2.0 (0.8–3.3) (n=36) 2.0 (1.0–3.8) (n=18) 1.0 (0.3–3.0) (n=18) 0.618
Prague classification M OGD2 (cm), median (IQR) 3.0 (2.0–5.0) (n=36) 3.0 (2.0–4.8) (n=18) 3.0 (2.3–5.0) (n=18) 0.521
Notes follow-up time (months), median (IQR) 76.0 (72.0–83.0) 76.0 (73.0–85.0) 75.0 (71.0–80.0) <0.001*
Deceased at time of notes follow-up, % (N) 32.1 (309) 26.1 (155) 41.7 (154) <0.001*
Deceased within 6 months of OGD1, % (N) 9.4 (91) 6.9 (41) 13.6 (50) 0.001*
Deceased within 12 months of OGD1, % (N) 11.8 (114) 8.2 (49) 17.6 (65) <0.001*
Time OGD1 to date of death (months), median (IQR) 24.0 (5.0–50.0) 27.0 (6.0–52.0) 18.5 (3.5–47.5) 0.086

*Statistically significant result (p<0.05). The Mann-Whitney U test compared continuous variables; the χ2 test compared categorical variables.

IM, intestinal metaplasia; OGD1, index endoscopic procedure; OGD2, repeat endoscopic procedure.